These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 6985936

  • 1. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM, Capel PJ, Koene RA.
    J Immunol; 1980 Feb; 124(2):719-23. PubMed ID: 6985936
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent.
    Capel PJ, Tamboer WP, de Waal RM, Jansen JL, Koene RA.
    J Immunol; 1979 Feb; 122(2):421-5. PubMed ID: 368240
    [Abstract] [Full Text] [Related]

  • 6. Enhancement and antibody-mediated rejection of mouse skin allografts with anti-H-2K, H-2D, H-2L antibodies.
    Capel PJ, de Waal RM, Démant P, Koene RA.
    Transplant Proc; 1981 Mar; 13(1 Pt 1):649-53. PubMed ID: 7268885
    [No Abstract] [Full Text] [Related]

  • 7. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT, Kinsky RG, Voisin GA.
    Ann Immunol (Paris); 1979 Mar; 130C(3):461-74. PubMed ID: 475347
    [Abstract] [Full Text] [Related]

  • 8. Isolation of pure IgG subclasses from mouse alloantiserum and their activity in enhancement and hyperacute rejection of skin allografts.
    Jansen JL, Gerard AP, Kamp J, Tamboer WP, Wijdeveld PG.
    J Immunol; 1975 Aug; 115(2):387-91. PubMed ID: 807636
    [Abstract] [Full Text] [Related]

  • 9. Ehancement and hyperacute rejection of skin grafts in the mousefailure to separate cytotoxic and enhancing antibodies from alloantiserum with physicochemical methods.
    Jansen JL, Koene RA, Kamp GJ, Gerlag PG, Wijdeveld PA.
    J Immunol; 1975 May; 114(5):1557-62. PubMed ID: 804518
    [Abstract] [Full Text] [Related]

  • 10. Passive enhancement of mouse tumor allografts by alloantibodies is Fc-dependent.
    de Waal RM, Cornelissen IM, Capel PJ, Koene RA.
    J Immunol; 1979 Sep; 123(3):1353-5. PubMed ID: 469254
    [Abstract] [Full Text] [Related]

  • 11. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS, Chase CM, Burton RC.
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [Abstract] [Full Text] [Related]

  • 12. Hyperacute rejection of skin allografts in the mouse. Sensitivity of ingrowing skin grafts to the action of alloantibody and rabbit complement.
    Gerlag PG, Koene RA, Hagemann JF, Wijdeveld PG.
    Transplantation; 1975 Oct; 20(4):308-13. PubMed ID: 1099736
    [Abstract] [Full Text] [Related]

  • 13. Evidence for the presence of idiotype-bearing regulatory T cells in which idiotype expression does not show linkage to either IgH alleles or the MHC.
    Singhai R, Weaver M, Sikora L, Levy JG.
    Immunology; 1984 Apr; 51(4):743-54. PubMed ID: 6423526
    [Abstract] [Full Text] [Related]

  • 14. Effect of alloantibodies on corneal allograft survival.
    Hegde S, Mellon JK, Hargrave SL, Niederkorn JY.
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [Abstract] [Full Text] [Related]

  • 15. Apparent lack of H-2 restriction of allograft rejection.
    Murasko DM.
    J Immunol; 1978 Sep; 121(3):958-61. PubMed ID: 80436
    [Abstract] [Full Text] [Related]

  • 16. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG, Liu Z, Wu Y.
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [Abstract] [Full Text] [Related]

  • 17. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
    Wu GD, He Y, Chai NN, Toyoda M, Dunn R, Kehry MR, Klein AS, Jordan SC.
    Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
    [Abstract] [Full Text] [Related]

  • 18. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
    Cavazzana-Calvo M, Sarnacki S, Haddad E, De Coene C, Calise D, Yvon E, Cerf-Bensussan N, Fischer A.
    Transplantation; 1995 Jun 15; 59(11):1576-82. PubMed ID: 7778173
    [Abstract] [Full Text] [Related]

  • 19. In vivo activity of an H-2 alloantiserum purified by affinity chromatography on transplantation antigens.
    de Waal RM, Lems SP, Koene RA.
    Transplantation; 1979 Jun 15; 27(6):376-9. PubMed ID: 380077
    [Abstract] [Full Text] [Related]

  • 20. Role of antiserum and complement in the acute antibody-mediated rejection of mouse skin allografts in strain combinations with increasing histoincompatibility.
    Berden JH, Gerlag PG, Hagemann JF, Koene RA.
    Transplantation; 1977 Sep 15; 24(3):175-82. PubMed ID: 339430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.